Arax Advisory Partners’s Strata Critical Medical, Inc. Class A Common Stock SRTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,548
| Closed | -$15.1K | – | 3052 |
|
|
2025
Q1 | $15.1K | Sell |
5,548
-2
| -0% | -$5 | ﹤0.01% | 1422 |
|
|
2024
Q4 | $23.6K | Buy |
5,550
+100
| +2% | +$425 | ﹤0.01% | 1147 |
|
|
2024
Q3 | $16K | Hold |
5,450
| – | – | ﹤0.01% | 1175 |
|
|
2024
Q2 | $19K | Buy |
5,450
+2
| +0% | +$7 | ﹤0.01% | 985 |
|
|
2024
Q1 | $15.5K | Hold |
5,448
| – | – | ﹤0.01% | 709 |
|
|
2023
Q4 | $19.2K | Hold |
5,448
| – | – | ﹤0.01% | 656 |
|
|
2023
Q3 | $14.1K | Hold |
5,448
| – | – | ﹤0.01% | 650 |
|
|
2023
Q2 | $21.5K | Hold |
5,448
| – | – | ﹤0.01% | 574 |
|
|
2023
Q1 | $18.4K | Hold |
5,448
| – | – | ﹤0.01% | 597 |
|
|
2022
Q4 | $19.5K | Hold |
5,448
| – | – | ﹤0.01% | 563 |
|
|
2022
Q3 | $22K | Hold |
5,448
| – | – | ﹤0.01% | 554 |
|
|
2022
Q2 | $24K | Hold |
5,448
| – | – | ﹤0.01% | 536 |
|
|
2022
Q1 | $46K | Hold |
5,448
| – | – | 0.01% | 465 |
|
|
2021
Q4 | $48K | Buy |
5,448
+5,000
| +1,116% | +$44.1K | 0.01% | 465 |
|
|
2021
Q3 | $5K | Hold |
448
| – | – | ﹤0.01% | 751 |
|
|
2021
Q2 | $5K | Buy |
+448
| New | +$5K | ﹤0.01% | 753 |
|
|
2020
Q4 | $10K | Buy |
+895
| New | +$10K | ﹤0.01% | 567 |
|